Clinical trials: Chest--Diseases
Acute Respiratory Failure, Pneumonia
HFCWO on Pneumonic Respiratory Failure
BACKGROUND: Endotracheal intubation and prolonged immobilization of patients receiving mechanical ventilation may reduce expectoration function.
- Trial name
- HFCWOonAFR (NCT02758106)
- Testing
- Vest Airway Clearance System Model 105
- Volunteers
- 73 people
- Sponsor
- Chung Shan Medical University
Small-cell Lung Cancer
RW Effectiveness of Lurbinectedin in Extensive Stage SCLC
LURBICLIN cohort will describe the demographic and clinical characteristics of patients who received at least one dose of lurbinectedin as part of ATU program.
- Trial name
- LURBICLIN (NCT05285033)
- Testing
- Lurbinectedin
- Where
- 2 sites in France
- Volunteers
- 312 people
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
Randomized phase III trial to compare the effectiveness of surgery with or without combination chemotherapy in treating patients who have stage I non-small cell lung cancer.
- Conditions
- Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer
- Trial name
- NCT00002852
- Testing
- paclitaxel, carboplatin, therapeutic conventional surgery
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- National Cancer Institute (NCI)
Cardiovascular Disease, Atherosclerosis
Cardiovascular Molecular Calcification Assessed by 18F-NaF PET CT
The purpose of the CAMONA study is to demonstrate the feasibility of cardiovascular molecular calcification (CMC) assessment by means of 18F-sodium-fluoride (18F-NaF) positron emission tomography (PET) computed tomography (CT) in…
- Conditions
- Cardiovascular Disease, Atherosclerosis, Angina Pectoris
- Trial name
- CAMONA (NCT01724749)
- Where
- 2 sites in Denmark
- Volunteers
- 144 people, healthy volunteers welcome
- Sponsor
- Odense University Hospital
Lung Cancer
Project Lung Cancer Screening in Southern Denmark
One thousand randomly selected voluntary citizens aged 60-74 years old, who are heavy current or former smokers with an increased risk of developing lung cancer may be included in the project.
- Trial name
- PLUS (NCT06537804)
- Testing
- Screening by low-dose CT scan
- Where
- 2 sites in Denmark
- Volunteers
- 1,332 people, healthy volunteers welcome
- Sponsor
- Odense University Hospital
NSCLC
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation
This study will be performed as a local multicenter, randomized, phase III clinical study. It will compare the adjuvant chemotherapy in Stage IB-IIIA NSCLC with common EGFR mutation (Exon 19 deletion or L858R) who underwent total…
- Trial name
- NCT02795884
- Testing
- intercalation therapy using pemetrexed, cisplatin and erlotinib, Vinorelbine, cisplatin
- Sponsor
- Yonsei University
Anxiety, Evidence-based Practice
The Effect of Music on Anxiety and Caregiver Burden in Family Caregivers of Patients With Lung Cancer
This randomized controlled trial evaluated the effects of a 7-day self-selected music intervention on caregiver burden and anxiety among first-degree family caregivers of patients with lung cancer.
- Conditions
- Anxiety, Evidence-based Practice, Caregiver Burden, Nursing
- Trial name
- NCT07847138
- Testing
- Music intervention
- Where
- Turkey (Türkiye)
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Izmir Bakircay University
Lung Cancer
Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma
Both pemetrexed and erlotinib are second-line treatment options for patients with advanced non-small cell lung cancer. It is controversial that whether it is necessary to detect epidermal growth factor receptor (EGFR) mutation…
- Trial name
- NCT01565538
- Testing
- Erlotinib, Pemetrexed
- Where
- China
- Volunteers
- 123 people
- Sponsor
- Si-Yu Wang
Thymoma
Robot-assisted vs VATS for Thymoma
The aim of this study is to explore the advantages of robot-assisted thymectomy in long-term survival benefits and short-term clinical efficacy compared with video-assisted thoracoscopic thymectomy based on a multi-center…
- Trial name
- NCT06029621
- Testing
- RATS for Thymectomy, VATS for Thymectomy
- Where
- 2 sites in China
- Volunteers
- 304 people
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
Leukemia, Lung Cancer
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
RATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill cancer cells. Biological therapies, such as GM-CSF, may stimulate the immune system in different ways and stop cancer cells from…
- Conditions
- Leukemia, Lung Cancer, Malignant Mesothelioma, Myelodysplastic Syndromes
- Trial name
- NCT00398138
- Testing
- WT-1 analog peptide vaccine, incomplete Freund's adjuvant, sargramostim
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Brain Cancer, Prostate Cancer
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)
The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.
- Conditions
- Brain Cancer, Prostate Cancer, Lung Cancer
- Trial name
- NCT01987193
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- University of Florida
Non-small Cell Lung Cancer (NSCLC)
Selumetinib in Combination With Gefitinib in NSCLC Patients
This is an open-label, non-randomized, multicenter phase Ib/II study, which is composed of a phase Ib dose escalation part and a phase II dose expansion part.
- Trial name
- NCT02025114
- Testing
- selumetinib
- Where
- 3 sites in Taiwan
- Volunteers
- 34 people
- Sponsor
- National Taiwan University Hospital
Non-Small-Cell Lung Carcinoma
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
This is an open label, prospective, multicenter, non-comparative study to assess the safety and effectiveness of Tabrecta® (Capmatinib) in real world setting.
- Trial name
- NCT05703516
- Testing
- Capmatinib
- Where
- 10 sites in South Korea
- Volunteers
- 44 people
- Sponsor
- Novartis Pharmaceuticals
Extensive-Stage Small Cell Lung Cancer
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
This proposed trial will investigate the combination of amrubicin and carboplatin in the first-line treatment of patients with extensive-stage small cell lung cancer (ES- SCLC).
- Trial name
- NCT01076504
- Testing
- Amrubicin, Carboplatin, Pegfilgrastim
- Where
- 20 sites in United States
- Volunteers
- 81 people
- Sponsor
- SCRI Development Innovations, LLC
Non-Small Cell Lung Cancer
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
This study was a single-center, single-arm clinical study to evaluate the safety and efficacy of hypervision proton surgery with single large fractionated doses (34GyE and 39GyE) in the treatment of early peripheral NSCLC.
- Trial name
- HyPROS-LC (NCT07195084)
- Testing
- Hypervision proton surgery
- Where
- China
- Volunteers
- 12 people
- Sponsor
- Anhui Provincial Cancer Hospital
Coronary Artery Disease, Chest Pain
Arterial Stiffness for Improved Prediction of Coronary Artery Disease by Coronary CT Angiography
This study will evaluate the ability of device-estimated pulse wave velocity and machine learning methods to improve the prediction of potential symptomatic coronary artery disease
- Conditions
- Coronary Artery Disease, Chest Pain, Dyspnea, Arterial Stiffness
- Trial name
- NCT06734247
- Testing
- Coronary computer tomography angiography (CCTA), Photoplethysmography (PPG) and single-lead ECG, Brachial single cuff-based arterial stiffness
- Where
- Sweden
- Volunteers
- 156 people
- Sponsor
- Danderyd Hospital
Breast Cancer, Cognitive/Functional Effects
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
RATIONALE: Questionnaires that assess symptoms caused by cancer and cancer therapy may help improve the ability to plan treatment for patients with invasive cancer to help them live longer and more comfortably.
- Conditions
- Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Lung Cancer
- Trial name
- NCT00303914
- Testing
- assessment of therapy complications, cognitive assessment, psychosocial assessment and care
- Where
- 32 sites in United States
- Volunteers
- 2,310 people
- Sponsor
- Eastern Cooperative Oncology Group
Small Cell Lung Cancer
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
The primary objective of this study is to demonstrate non-inferiority in pharmacokinetic (PK) parameters of subcutaneous (SC) vs intravenous (IV) tarlatamab administration and to characterize the efficacy, safety, and…
- Trial name
- DeLLphi-315 (NCT07778316)
- Testing
- Tarlatamab
- Where
- 9 sites in United States, Australia and 3 more
- Volunteers
- 400 people
- Sponsor
- Amgen
Lung Cancer
The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis
Immune checkpoint inhibitors have revolutionized lung cancer (LC) treatment, demonstrating a significant improvement in overall survival.
- Trial name
- NCT05326906
- Testing
- PD-1/PD-L1 inhibitors
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Hunan Province Tumor Hospital
Non Small Cell Lung Cancer, Advanced Cancer
Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer
Lung cancer is one of the most common causes of cancer death worldwide. It is projected that the vast majority, approximately 80% -85% of all lung cancer diagnosis is Non-Small Cell Lung Cancer (NSCLC).
- Conditions
- Non Small Cell Lung Cancer, Advanced Cancer, Refractory Cancer
- Trial name
- NCT04840004
- Testing
- PVT-1
- Where
- 4 sites in Turkey (Türkiye)
- Volunteers
- 24 people
- Sponsor
- PlusVitech S.L.
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.